Image

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

Recruiting
18 years and older
Both
Phase 1
  • Simplified (AI rewritten)
  • Technical (Original)

This study is testing an experimental drug called linvoseltamab for a type of blood cancer known as multiple myeloma. Multiple myeloma is a cancer that affects white blood cells in the bone marrow. The research aims to find out if linvoseltamab, when combined with other cancer treatments, can help patients whose current treatments are no longer effective. The study will also determine if this combination is safe and identify the correct dosage. Participants must have already tried other cancer treatments and must meet certain health criteria to join. This study will track how the drug works in the body, any side effects, and how the immune system responds to it. Joining this study could help researchers develop better treatments for multiple myeloma.

  • Participants must have tried at least 2-3 previous treatments.
  • The study involves multiple visits and health checks.
  • Potential side effects and drug interactions will be monitored.
Print
Study details
    Multiple Myeloma

NCT05137054

Regeneron Pharmaceuticals

11 July 2024

Contact a study center
Not finding the right Trial?

You can also call our Patient navigators who can help you to find the right trial.

Call now
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.